John N Nacey
Overview
Explore the profile of John N Nacey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
167
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lamb D, Greig L, FitzJohn T, Russell G, Nacey J, Iupati D, et al.
Brachytherapy
. 2020 Nov;
20(2):291-295.
PMID: 33158775
Purpose: When biochemical failure (BF) develops after low-dose-rate prostate brachytherapy, the relapse site is frequently not found. We set out to find whether prostate-specific membrane antigen positron emission tomography -CT...
2.
Delahunt B, Srigley J, Judge M, Amin M, Billis A, Camparo P, et al.
J Clin Pathol
. 2019 Jul;
72(9):573-578.
PMID: 31300532
The International Collaboration on Cancer Reporting (ICCR) has developed a suite of detailed datasets for international implementation. These datasets are based on the reporting protocols developed by the Royal College...
3.
Lamb D, Greig L, Russell G, Nacey J, Broome K, Jain M, et al.
N Z Med J
. 2018 Nov;
131(1485):13-18.
PMID: 30408814
Aim: New Zealand men diagnosed with early stage prostate cancer need to know what outcomes to expect from management options. Methods: Between 2001 and 2016, 951 men were treated with...
4.
Delahunt B, Srigley J, Judge M, Amin M, Billis A, Camparo P, et al.
Histopathology
. 2018 Oct;
74(3):377-390.
PMID: 30325065
Aims: The International Collaboration on Cancer Reporting (ICCR) has provided detailed data sets based upon the published reporting protocols of the Royal College of Pathologists, the Royal College of Pathologists...
5.
Lamb D, Sondhauss S, Dunne J, Woods L, Delahunt B, Ferguson P, et al.
Anticancer Res
. 2017 Dec;
37(12):6943-6946.
PMID: 29187477
Background/aim: We previously reported the use of mass spectrometry and western blotting to identify proteins from tumour regions of formalin-fixed paraffin-embedded biopsies from 16 men who presented with apparently localized...
6.
Samaratunga H, Delahunt B, Srigley J, Yaxley J, Johannsen S, Coughlin G, et al.
Histopathology
. 2017 Jun;
71(4):641-647.
PMID: 28590015
Aim: The clinical significance of mucinous prostatic adenocarcinoma (PCa) remains uncertain. Methods: From 6440 cases of PCa treated by radical prostatectomy from 2009 to 2014, mucinous components of 5-100% were...
7.
Delahunt B, Egevad L, Samaratunga H, Martignoni G, Nacey J, Srigley J
Histopathology
. 2016 Mar;
69(2):341-2.
PMID: 26989872
No abstract available.
8.
Dunne J, Lamb D, Delahunt B, Murray J, Bethwaite P, Ferguson P, et al.
Clin Proteomics
. 2015 Sep;
12(1):24.
PMID: 26388710
Background: Prostate cancer is the most frequently diagnosed cancer in men and the third leading cause of cancer related deaths among men living in developed countries. Biomarkers that predict disease...
9.
Delahunt B, Egevad L, Samaratunga H, Martignoni G, Nacey J, Srigley J
Histopathology
. 2015 Aug;
68(4):475-81.
PMID: 26266664
Grading is an important prognostic parameter for prostate adenocarcinoma and renal cell carcinoma (RCC); however, the most frequently used classifications fail to account for advances in our understanding of the...
10.
Samaratunga H, Delahunt B, Egevad L, Adamson M, Hussey D, Malone G, et al.
Histopathology
. 2015 Jul;
68(4):533-40.
PMID: 26211928
Aims: Vesical pleomorphic giant cell carcinoma (PGCC) is a variant of urothelial carcinoma (UC) characterized by highly pleomorphic tumour with giant cells. Fewer than 10 cases have been reported, and...